Lipid peroxidation and immune activation: TRAF3’s double-edged strategy against glioblastoma
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci190471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Tzu-Yi Chia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, and. Hauptthemen laut MEDLINE: Glioblastoma, Lipid Peroxidation, Brain Neoplasms, TNF Receptor-Associated Factor 3. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, and.
- Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago Illinois, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Chia, T. Y., Sadagopan, N. S., & Miska, J. (2025). Lipid peroxidation and immune activation: TRAF3’s double-edged strategy against glioblastoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci190471
Vancouver
Chia TY, Sadagopan NS, Miska J. Lipid peroxidation and immune activation: TRAF3’s double-edged strategy against glioblastoma. Journal of Clinical Investigation. 2025. doi:10.1172/jci190471
BibTeX
@article{Chia2025,
author = {Chia, Tzu-Yi and Sadagopan, Nishanth S and Miska, Jason},
title = {Lipid peroxidation and immune activation: TRAF3’s double-edged strategy against glioblastoma},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci190471}
}
EUVIMED